关注
Senthil Visaga Ambi
Senthil Visaga Ambi
SASTRA DEEMED TO BE UNIVERSITY
在 scbt.sastra.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
S Muralidar, SV Ambi, S Sekaran, UM Krishnan
Biochimie 179, 85-100, 2020
3712020
Role of tau protein in Alzheimer's disease: The prime pathological player
S Muralidar, SV Ambi, S Sekaran, D Thirumalai, B Palaniappan
International journal of biological macromolecules 163, 1599-1617, 2020
1642020
Repeated fed-batch process for improving lovastatin production
MS Kumar, SK Jana, V Senthil, V Shashanka, SV Kumar, AK Sadhukhan
Process Biochemistry 36 (4), 363-368, 2000
1272000
Withanolide induces apoptosis in HL-60 leukemia cells via mitochondria mediated cytochrome c release and caspase activation
V Senthil, S Ramadevi, V Venkatakrishnan, P Giridharan, BS Lakshmi, ...
Chemico-biological interactions 167 (1), 19-30, 2007
702007
Chicken egg yolk antibody (IgY) as diagnostics and therapeutics in parasitic infections–a review
D Thirumalai, SV Ambi, RS Vieira-Pires, Z Xiaoying, S Sekaran, ...
International journal of biological macromolecules 136, 755-763, 2019
532019
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment
R Tandon, S Kapoor, S Vali, V Senthil, D Nithya, R Venkataramanan, ...
European journal of pharmacology 667 (1-3), 56-65, 2011
442011
Emerging therapeutic interventions for idiopathic pulmonary fibrosis
S Chakraborty, P Chopra, SV Ambi, SG Dastidar, A Ray
Expert opinion on investigational drugs 23 (7), 893-910, 2014
382014
Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19
S Muralidar, G Gopal, S Visaga Ambi
Journal of Medical Virology 93 (9), 5260-5276, 2021
332021
Inflammation in myocardial injury-Stem cells as potential immunomodulators for myocardial regeneration and restoration
S Vadivel, P Vincent, S Sekaran, SV Ambi, S Muralidar, V Selvaraj, ...
Life sciences 250, 117582, 2020
192020
Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase
P Chopra, O Kulkarni, S Gupta, M Bajpai, V Kanoje, M Banerjee, V Bansal, ...
International immunopharmacology 10 (4), 467-473, 2010
192010
Passive immunotherapy using chicken egg yolk antibody (IgY) against diarrheagenic E. coli: a systematic review and meta-analysis
M Karthikeyan, ST Indhuprakash, G Gopal, SV Ambi, UM Krishnan, ...
International Immunopharmacology 102, 108381, 2022
122022
RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy
R Tandon, V Senthil, D Nithya, V Pamidiboina, A Kumar, S Malik, T Chaira, ...
European journal of pharmacology 711 (1-3), 19-26, 2013
102013
The concept of big four: road map from snakebite epidemiology to antivenom efficacy
G Gopal, S Muralidar, D Prakash, A Kamalakkannan, ST Indhuprakash, ...
International journal of biological macromolecules 242, 124771, 2023
62023
Synbiotics in Lung Cancer
D Prakash, SK Venkataramanan, G Gopal, S Muralidar, SV Ambi
Synbiotics for the Management of Cancer, 191-204, 2023
32023
Microbiome in Acute Respiratory Distress Syndrome (ARDS)
G Gopal, S Muralidar, A Kamalakkannan, SV Ambi
Microbiome in Inflammatory Lung Diseases, 117-134, 2022
32022
Antibody Therapy Against Antibiotic-Resistant Diarrheagenic Escherichia Coli: A Systematic Review
S Thuthikkadu Indhuprakash, M Karthikeyan, G Gopal, SV Ambi, ...
Immunotherapy 13 (15), 1305-1320, 2021
32021
Systematic review and meta-analysis on the efficacy of Indian polyvalent antivenom against the Indian snakes of clinical significance
G Gopal, H Selvaraj, SK Venkataramanan, S Venkataraman, ...
Archives of toxicology 98 (2), 375-393, 2024
12024
Future Scope of Biosimilars for the Treatment of Various Cancers
A Subramanian, GD Muthukumarasamy, S Venkataraman, K Rangasamy, ...
Biosimilars for Cancer Treatment: A Promising Approach, 287-309, 2024
2024
Development of chicken egg yolk antibodies (IgY) against venom of cobra (Naja naja) and krait (Bungarus caeruleus) and a study on its neutralization potential
G Gopal, M Antonysamy, S Visaga Ambi, D Thirumalai
Toxin Reviews, 1-21, 2024
2024
Synergistic Potential of Antigen-Specific Vaccines and Immunomodulatory Agents for Lung Cancer Treatment
SK Venkataramanan, NS Raman, K Rangasamy, SG Ganapathy, ...
Immunotherapy Against Lung Cancer: Emerging Opportunities and Challenges …, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20